BERAPROST for Systemic scleroderma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where BERAPROST was used for Systemic scleroderma.
Most Reported Side Effects for BERAPROST
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 34 | 14.6% | 5 | 30 |
| Dyspnoea | 33 | 14.2% | 5 | 30 |
| Pulmonary hypertension | 30 | 12.9% | 8 | 23 |
| Off label use | 28 | 12.0% | 5 | 20 |
| Nausea | 20 | 8.6% | 6 | 16 |
| Cardiac failure | 17 | 7.3% | 6 | 13 |
| Condition aggravated | 17 | 7.3% | 3 | 12 |
| Diarrhoea | 17 | 7.3% | 4 | 15 |
| Right ventricular failure | 17 | 7.3% | 7 | 14 |
| Anaemia | 15 | 6.4% | 2 | 12 |
| Dizziness | 15 | 6.4% | 1 | 11 |
| Syncope | 15 | 6.4% | 3 | 13 |
| Pulmonary arterial hypertension | 14 | 6.0% | 7 | 10 |
| Acute kidney injury | 13 | 5.6% | 3 | 12 |
| Hypotension | 13 | 5.6% | 3 | 8 |
Other Indications for BERAPROST
Pulmonary arterial hypertension (115)
Product used for unknown indication (36)
Pulmonary hypertension (25)
Peripheral arterial occlusive disease (5)
Other Drugs Used for Systemic scleroderma
RITUXIMAB (554)
MYCOPHENOLATE MOFETIL (474)
TOCILIZUMAB (332)
METHOTREXATE (307)
NINTEDANIB (204)
PREDNISOLONE (156)
CYCLOPHOSPHAMIDE (142)
PREDNISONE (128)
BOSENTAN (120)
IMATINIB (118)